Company profile

Armāitide

Develop first-in-class targeted cancer therapies helping patients with aggressive cancers benefit from precision therapy

Industry
Biotechnology Research
Employees
1
Founded
2026

Armāitide company summary

Armāitide is a company in the Biotechnology Research industry, founded in 2026. On LinkedIn the company has around 1 employees.

What technology does Armāitide use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Armāitide

Armāitide is a biotechnology company developing next-generation targeted cancer therapeutics to improve outcomes for patients with aggressive and difficult-to-treat cancers. Inspired by the ancient Persian concept of Armāity, representing devotion, wisdom, and enduring care, Armāitide combines this philosophy with the precision of peptide-guided drug delivery to create innovative therapies that selectively target cancer cells while aiming to reduce off-target toxicity. Our platform leverages engineered peptide-based targeting technologies to deliver potent therapeutic payloads directly to tumours, with an initial focus on oncology indications with significant unmet clinical need. By integrating advances in peptide engineering, targeted therapeutics, and translational medicine, we are building a pipeline of precision therapies designed to transform the way cancer is treated. At Armāitide, we believe that scientific excellence, patient-centred innovation, and enduring commitment to those affected by cancer are fundamental to creating meaningful therapeutic advances. Targeted Therapies for Cancer Care.

Compare companies similar to Armāitide

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Armāitide
armaitide.com
Biotechnology Research12026-
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Armāitide

What does Armāitide do?

Armāitide is a biotechnology company developing next-generation targeted cancer therapeutics to improve outcomes for patients with aggressive and difficult-to-treat cancers. Inspired by the ancient Persian concept of Armāity, representing devotion, wisdom, and enduring care, Armāitide combines this philosophy with the precision of peptide-guided drug delivery to create innovative therapies that selectively target cancer cells while aiming to reduce off-target toxicity. Our platform leverages engineered peptide-based targeting technologies to deliver potent therapeutic payloads directly to tumours, with an initial focus on oncology indications with significant unmet clinical need. By integrating advances in peptide engineering, targeted therapeutics, and translational medicine, we are building a pipeline of precision therapies designed to transform the way cancer is treated. At Armāitide, we believe that scientific excellence, patient-centred innovation, and enduring commitment to those affected by cancer are fundamental to creating meaningful therapeutic advances. Targeted Therapies for Cancer Care.

How many employees does Armāitide have?

Armāitide has around 1 employees on LinkedIn.

When was Armāitide founded?

Armāitide was founded in 2026.

Build a lead list from companies like Armāitide

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.